NRG4 and fatty liver disease: As a ligand, NRG4 predominantly activates the ErbB4 receptor, initiating ErbB3/ErbB4 signaling in hepatocytes and exerting protective effects against diet-induced insulin resistance and hepatic steatosis, partly by attenuating hepatic de novo lipogenesis.